Какова цена за Metagenomi, Inc. Common Stock (MGX)

Цена за Metagenomi, Inc. Common Stock (MGX) Это $1.21

Какова рыночная капитализация для Metagenomi, Inc. Common Stock (MGX)

Рыночная капитализация для Metagenomi, Inc. Common Stock (MGX) Это $45.55M

Metagenomi, Inc. Common Stock (MGX) Акции в обращении

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.

Год	Акции в обращении	Изменить
Недостаточно данных для указанных дат.

Год

Акции в обращении

Изменить

Недостаточно данных для указанных дат.

Компания	Акции в обращении	Разница	Страна
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Argenx SE ARGX.US	62.19M	-	NL
CSL Limited CSL.AX	483.58M	-	AU
Lonza Group AG LONN.SW	-	-	CH
Moderna, Inc. MRNA.US	396.00M	-	US

Компания

Акции в обращении

Разница

Страна